Feedback    Advertise    Submit Papers    Reprints    About    Help    Contact   
Upstream Processing Downstream Processing Manufacturing Analytical Facilities
Archive by Issue Archive by Article Type Supplements
CMC Forum Press Releases
Broadening the Baseline
May 2013
Part 2: BPSA Focuses on End-User Concerns

FDA Biopharmaceutical Product Approvals and Trends in 2012

March 2013

Up from 2011, but Innovation and Impact Are Limited

 
Artifacts of Virus Filter Validation
May 2013
Best Practices to Maintain the Scaled-Down Model
Purifying Common Light-Chain Bispecific Antibodies
May 2013
A Twin-Column, Countercurrent Chromatography Platform Process
 
Advances in Sensor Technology Improve Biopharmaceutical Development
April 2013
Tunable Half-Life Technology
March 2013
Redefining the Rules of Drug Dosing Frequency?
 
Bioengineered Ears: The Latest Advance
May 2013
Women Helping Women in Biotechnology
April 2013
 
Industry Events and Conferences
IBC's Biopharmaceutical Development & Production Week
March 24, 2014, Hilton Bayfront Hotel San Diego, CA
IBC's Flexible Facilities
February 20, 2014, Claremont Hotel & Spa, Berkeley, CA
 
WEBINAR – Purification strategies for a diversity of monoclonal antibodies

Join Annika Forss as she discusses the MAb chromatography toolbox and guidelines for the selection of media (resins) and steps to meet specific processing targets. The understanding you gain of the effects of different factors in the experimental space allows you to make an informed selection from different processes, including one or two polishing steps, depending on the level of the purification challenge.

Date: Wednesday, May 29th 2013

Time:
Event 1: Europe 08:00 CET / New Dehli 11:30 IST / Beijing 14:00 CST / Sydney 16:00 EDT
Event 2: Europe 14:00 CET / North America 08:00 EDT
Event 3: Europe 17:00 CET / North America 11:00 EDT

Speaker: Annika Forss, GE Healthcare Life Sciences

Register to attend the webinar.





Editors' Blog
How Cost-Effective Are US Cancer Prevention Services?
Dutch Public Health Service as Successful as U.S Private Services, but With Less Screening
Bioreactor Design and Bioprocess Controls for Industrialized Cell Processing Fed-Batch Cell Culture Process Optimization Strategies for Rapid Production of Therapeutic Proteins in Mammalian Cells Artifacts of Virus Filter Validation Trends in Perfusion Bioreactors

FDA Biopharmaceutical Product Approvals and Trends in 2012

Current Issue   
Archive   
Supplements   
BPI Extra!   
CMC Forum   
Author Guidelines   
BPA Qualified   
Editors' Blog   
Webinars   
Subscribe   
Advertiser / Media Kit   
Reprints   
List Rentals   
Contact   
About   
Privacy Policy   
Informa plc
©2002 - 2009 BioProcess International
Ph: 508-616-5550
info@bioprocessintl.com

In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer.

By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way BioProcess International uses cookies please go to our Cookie Policy page.